554 related articles for article (PubMed ID: 26092119)
1. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
5. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
6. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
Di Zhang A; Nguyen Dinh Cat A; Soukaseum C; Escoubet B; Cherfa A; Messaoudi S; Delcayre C; Samuel JL; Jaisser F
Hypertension; 2008 Dec; 52(6):1060-7. PubMed ID: 18981328
[TBL] [Abstract][Full Text] [Related]
8. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
[TBL] [Abstract][Full Text] [Related]
9. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
[TBL] [Abstract][Full Text] [Related]
10. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
11. Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction.
Cappetta D; De Angelis A; Flamini S; Cozzolino A; Bereshchenko O; Ronchetti S; Cianflone E; Gagliardi A; Ricci E; Rafaniello C; Rossi F; Riccardi C; Berrino L; Bruscoli S; Urbanek K
J Cell Mol Med; 2021 Jan; 25(1):217-228. PubMed ID: 33247627
[TBL] [Abstract][Full Text] [Related]
12. Direct Actions of AT
Sparks MA; Rianto F; Diaz E; Revoori R; Hoang T; Bouknight L; Stegbauer J; Vivekanandan-Giri A; Ruiz P; Pennathur S; Abraham DM; Gurley SB; Crowley SD; Coffman TM
Hypertension; 2021 Feb; 77(2):393-404. PubMed ID: 33390039
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice.
Tsuruda T; Sekita-Hatakeyama Y; Hao Y; Sakamoto S; Kurogi S; Nakamura M; Udagawa N; Funamoto T; Sekimoto T; Hatakeyama K; Chosa E; Kato J; Asada Y; Kitamura K
Hypertension; 2016 May; 67(5):848-56. PubMed ID: 27001297
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
Kudo H; Kai H; Kajimoto H; Koga M; Takayama N; Mori T; Ikeda A; Yasuoka S; Anegawa T; Mifune H; Kato S; Hirooka Y; Imaizumi T
Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
[TBL] [Abstract][Full Text] [Related]
16. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
[TBL] [Abstract][Full Text] [Related]
17. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
18. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
[TBL] [Abstract][Full Text] [Related]
20. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]